You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent locally advanced tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Solid Tumor Trial in Scottsdale, Aurora, Nashville (SQZ-eAPC-HPV, Pembrolizumab)

Recruiting
  • Adult Solid Tumor
  • SQZ-eAPC-HPV
  • Pembrolizumab
  • Scottsdale, Arizona
  • +4 more
Jan 26, 2023

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Pittsburgh, Pennsylvania
    Allyson Welsch
Jul 21, 2022

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Best Practice, Educational Intervention,

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Recurrent Malignant Solid Neoplasm
  • Best Practice
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Adult Solid Tumor Trial in Spain, United States (SQZ-AAC-HPV, Ipilimumab, Nivolumab)

Recruiting
  • Adult Solid Tumor
  • SQZ-AAC-HPV
  • +2 more
  • Duarte, California
  • +5 more
Aug 12, 2022

NSCLC Trial in Ankara, Istanbul (RS-0139)

Recruiting
  • NSCLC
  • Ankara, Turkey
  • +1 more
Jan 17, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Solid Tumor, Metastatic Tumor, Locally Advanced Malignant Tumor Trial in United States (SNDX-6352, Durvalumab)

Completed
  • Solid Tumor
  • +3 more
  • Scottsdale, Arizona
  • +4 more
Aug 17, 2022

Adult Solid Tumor Trial in Canada, Germany, United States (SQZ-PBMC-HPV, Atezolizumab, Ipilimumab)

Active, not recruiting
  • Adult Solid Tumor
  • SQZ-PBMC-HPV
  • +3 more
  • Scottsdale, Arizona
  • +12 more
Jan 17, 2023

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Metastasis, Locally Advanced Solid Tumor, Recurrent Cancer Trial in Stanford, New York (XRD-0394, Palliative radiotherapy)

Recruiting
  • Metastasis
  • +2 more
  • Stanford, California
  • +1 more
Sep 27, 2021

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced

Recruiting
  • Esophageal Neoplasms
  • an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Apr 21, 2022

Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Recurrent Vulvar Cancer
  • +3 more
  • (no location specified)
Jun 12, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Nintedanib in Indian Non-small Cell Lung Cancer After First-line

Completed
  • Non-small Cell Lung Cancer
    • Anand, India
    • +10 more
    Oct 12, 2022

    Locally Advanced Head-and-Neck Cancer Trial in Heidelberg (C12 re-irradiation, Photon re-irradiation)

    Recruiting
    • Locally Advanced Head-and-Neck Cancer
    • C12 re-irradiation
    • Photon re-irradiation
    • Heidelberg, Germany
      University Hospital of Heidelberg, Radiation Oncology
    Nov 2, 2022

    Locally Advanced or Metastatic Solid Tumors Trial in China (IN10018+PLD, IN10018+PLD+Toripalimab)

    Active, not recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • Anyang, Henan, China
    • +6 more
    Apr 25, 2023

    Radiotherapy - Comprehensive Radiobiology Assessment TRial

    Not yet recruiting
    • Locally Advanced Cervical Carcinoma
    • +9 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 1, 2023

      GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

      Not yet recruiting
      • Salivary Gland Cancer
      • Observation
      • (no location specified)
      Oct 13, 2023

      Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

      Not yet recruiting
      • Metastatic Breast Cancer
      • (no location specified)
      Oct 7, 2023

      Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

      Not yet recruiting
      • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Sep 12, 2023

      Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

      Not yet recruiting
      • Locally Advanced Solid Tumors
      • +2 more
      • (no location specified)
      Sep 4, 2023

      Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

      Recruiting
      • Recurrent Skin Squamous Cell Carcinoma
      • +4 more
      • Cemiplimab
      • Resection
      • Los Angeles, California
      • +2 more
      Nov 12, 2022